Patents by Inventor Rakesh Kundu

Rakesh Kundu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detecting interactions with non-discretized items and associating interactions with actors using digital images
    Patent number: 11922729
    Abstract: Commercial interactions with non-discretized items such as liquids in carafes or other dispensers are detected and associated with actors using images captured by one or more digital cameras including the carafes or dispensers within their fields of view. The images are processed to detect body parts of actors and other aspects therein, and to not only determine that a commercial interaction has occurred but also identify an actor that performed the commercial interaction. Based on information or data determined from such images, movements of body parts associated with raising, lowering or rotating one or more carafes or other dispensers may be detected, and a commercial interaction involving such carafes or dispensers may be detected and associated with a specific actor accordingly.
    Type: Grant
    Filed: February 13, 2023
    Date of Patent: March 5, 2024
    Assignee: Amazon Technologies, Inc.
    Inventors: Kaustav Kundu, Pahal Kamlesh Dalal, Nishitkumar Ashokkumar Desai, Jayakrishnan Kumar Eledath, Geoffrey A. Franz, Gerard Guy Medioni, Hoi Cheung Pang, Rakesh Ramakrishnan
  • Synergistic pharmaceutical composition useful for the treatment of lung cancer
    Patent number: 9622987
    Abstract: The present invention relates to a synergistic pharmaceutical composition comprising Compound C2 (Neo-isopulegol), C3 (Iso-pulegol) and C4 (Citronellol) derived from herbal seed extract of Litsea cubeba useful for the treatment of lung cancer. The present invention also relates to the activity of compounds C2 or C3 or C4 either alone or in combination in killing of A549 lung cancer cells.
    Type: Grant
    Filed: September 5, 2012
    Date of Patent: April 18, 2017
    Assignee: Council of Scientific & Industrial Research
    Inventors: Mantu Bhuyan, Pranab Ram Bhattacharyya, Pranab Kumar Baruah, Nabin Chandra Barua, Paruchuri G. Rao, Sushmita Bhattacharya, Rakesh Kundu, Priyajit Chatterjee, Soma Seal, Sandeep Mukherjee, Suman Dasgupta, Sudipta Moitra, Shelley Bhattacharya, Samir Bhattacharya
  • SYNERGISTIC PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF LUNG CANCER
    Publication number: 20150328170
    Abstract: The present invention relates to a synergistic pharmaceutical composition comprising Compound C2 (Neo-isopulegol), C3 (Iso-pulegol) and C4 (Citronellol) derived from herbal seed extract of Litsea cubeba useful for the treatment of lung cancer. The present invention also relates to the activity of compounds C2 or C3 or C4 either alone or in combination in killing of A549 lung cancer cells.
    Type: Application
    Filed: September 5, 2012
    Publication date: November 19, 2015
    Applicants: Visva-Bharati, Council of Scientific & Industrial Research
    Inventors: Mantu Bhuyan, Pranab Ram Bhattacharyya, Pranab Kumar Baruah, Nabin Chandra Barua, Paruchuri Gangadhar Rao, Sushmita Bhattacharya, Rakesh Kundu, Priyajit Chatterjee, Soma Seal, Sandeep Mukherjee, Suman Dasgupta, Sudipta Moitra, Shelley Bhattacharya, Samir Bhattacharya
  • Insulin Mimetic Active Comprising Oxodiperoxo Vanadates and a Pharmaceutical Composition Obtained Thereof
    Publication number: 20140018340
    Abstract: A pharmaceutically acceptable peroxovanadium(v) amine product, DmpzH[VO(02)2](Dmpz)], and its oral as well as injectable use for the treatment of Diabetes mellitus, wherein the said therapeutically stable compound is obtained by reacting V205 or vanadate with hydrogen peroxide and the amine, dimethylpyrazole (Dmpz), at pH 5.5 and temperature 0-4° C. DmpzH[VO(02)2](Dmpz)] is thus poised as a versatile insulin mimic adapted for targeting insulin signaling, stimulating adipogenesis, abrogating insulin stimulated down stream signals thereby lowering the incidence of insulin resistance and type-2 diabetes.
    Type: Application
    Filed: June 9, 2011
    Publication date: January 16, 2014
    Inventors: Mihir K. Chaudhuri, Sahid Hussain, Saitanya Bharadwaj, Upasana Bora Sinha, Dhrubajyoti Talukdar, Subeer Suhash Majumdar, Sushmita Bhattacharya, Suman Dasgupta, Rakesh Kundu, Samir Bhattacharya, Shelley Bhattacharya, Abul Usmani